efavirenz/emtricitabina/tenofovir disoproxilo sandoz efg 600/200/245 mg 30 comprimits recoberts
efavirenz+emtricitabina+tenofovir - comprimits atripla
efavirenz/emtricitabina/tenofovir disoproxilo dr reddys efg 600/200/245 mg 30 comprimits recob
efavirenz+emtricitabina+tenofovir - comprimits atripla
stribild
gilead sciences pty ltd - cobicistat; tenofovir disoproxil fumarate; emtricitabine; elvitegravir -
stribild
gilead sciences (nz) - cobicistat 150mg; ; ; ; elvitegravir 150mg; ; ; emtricitabine 200mg; ; ; ; ; tenofovir disoproxil fumarate 300mg; ; ; - film coated tablet - active: cobicistat 150mg elvitegravir 150mg emtricitabine 200mg tenofovir disoproxil fumarate 300mg excipient: colloidal silicon dioxide croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry green sodium laurilsulfate - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-naive adults. stribild is also indicated in certain virologically suppressed (hiv1 rna stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.
stribild tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottle
gilead sciences pty ltd - tenofovir disoproxil fumarate, quantity: 300 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; silicon dioxide; croscarmellose sodium; magnesium stearate; sodium lauryl sulfate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - stribild is indicated as a single tablet regimen for the treatment of hiv infection in treatment-na?ve adults. stribild is also indicated in certain virologically suppressed (hiv1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of stribild (tenofovir df, emtricitabine or elvitegravir). stribild is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.
eviplera
gilead sciences pty ltd - tenofovir disoproxil fumarate; rilpivirine hydrochloride; emtricitabine -
hepsera
gilead sciences pty ltd - adefovir dipivoxil -
stocrin
merck sharp & dohme australia pty ltd - efavirenz -
truvada
gilead sciences pty ltd - emtricitabine; tenofovir disoproxil fumarate -
viread
gilead sciences pty ltd - tenofovir disoproxil fumarate -